Delivery Order 47QRAA20D0072-75FCMC23F0132

Ended Awarded Last action

Contract number
75FCMC23F0132
Awardee
Awarding agency
Obligated
$3,236,397

Award facts

Contract value 92% obligated
  • $3,236,397.00 Current, with exercised options
  • $3,532,789.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20009, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 $1,506,280
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award Medicare advantage and prescription drug plan monitoring methods $1,730,117

About this award

The Centers for Medicare and Medicaid Services (CMS) awarded a delivery order valued at $3.53 million to L&M Policy Research, LLC on September 30, 2023, with an ultimate completion date of September 29, 2027. This firm fixed price contract supports CMS's Medicare Advantage and Prescription Drug Plan monitoring methods, issued under the Consumer Research and Communication IV (CRC IV) Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle. The CRC IV IDIQ, a $98 million total small business set-aside awarded to L&M in September 2022, provides CMS with comprehensive consumer research and communications services to support outreach, education, and communication efforts across Medicare programs.

L&M Policy Research, LLC, a Washington, DC-based minority-owned and women-owned small business specializing in healthcare policy research and consulting, is well-positioned to execute this work. The company has extensive experience supporting CMS's initiatives through its established IDIQ vehicles and prior task orders focused on Medicare research and consumer engagement. Work will be performed in Washington, DC, and the contract contains no set-aside designation beyond the underlying small business set-aside of the parent CRC IV IDIQ. This delivery order represents continued investment in L&M's core competency of monitoring and evaluating Medicare program performance through evidence-based research methodologies.

Quick answers

Who was awarded contract 75FCMC23F0132?

75FCMC23F0132 was awarded to L&M Policy Research, LLC by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on September 30, 2023.

How much is contract 75FCMC23F0132 worth?

The government has obligated $3,236,397 on 75FCMC23F0132. Its potential value, with all options, is $3,532,789.

Is contract 75FCMC23F0132 an order under another contract?

Yes. 75FCMC23F0132 is a delivery order under 47QRAA20D0072, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75FCMC23F0132 competed?

The extent of competition for 75FCMC23F0132 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award